Keld Laursen

15 catalog papers. Identity-linked publications and additional name matches are distinguished below.

ORCID: 0000-0002-2763-3989

Copenhagen Business School

Publications

• Technological competition and patent strategy: Protecting innovation, preempting rivals and defending the freedom to operate — Research Policy 2023
• Inbound Open Innovation and Innovation Performance: A Robustness Study — Research Policy 2021
• Mounting corporate innovation performance: The effects of high-skilled migrant hires and integration capacity — Research Policy 2020
• Experience matters: The role of academic scientist mobility for industrial innovation — Strategic Management Journal 2018
• Knowledge diversity and coordination: The effect of intrafirm inventor task networks on absorption speed — Strategic Management Journal 2018
• Evading the Boomerang Effect: Using the Grant-Back Clause to Further Generative Appropriability from Technology Licensing Deals — Organization Science 2017
• The paradox of openness: Appropriability, external search and collaboration — Research Policy 2014
• Trapped or spurred by the home region? The effects of potential social capital on involvement in foreign markets for goods and technology — Journal of International Business Studies 2012
• Regions Matter: How Localized Social Capital Affects Innovation and External Knowledge Acquisition — Organization Science 2012
• Linking Customer Interaction and Innovation: The Mediating Role of New Organizational Practices — Organization Science 2011
• The role of ICT knowledge flows for international market share dynamics — Research Policy 2010
• The role of lead users in knowledge sharing — Research Policy 2009
• Open for innovation: the role of openness in explaining innovation performance among U.K. manufacturing firms — Strategic Management Journal 2006
• Searching high and low: what types of firms use universities as a source of innovation? — Research Policy 2004
• Horizontal diversification in the Danish national system of innovation: the case of pharmaceuticals — Research Policy 1996